Retour
Fourchette du Jour
76,42 €
80,28 €
Fourchette 52 Semaines
13,37 €
88,02 €
Volume
852 060
Moyenne 50J / 200J
56,34 €
/
37,05 €
Clôture Précédente
79,32 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -17,5 | 0,3 |
| P/B | 5,8 | 2,9 |
| ROE % | -38,4 | 3,7 |
| Net Margin % | -7973,3 | 3,8 |
| Rev Growth 5Y % | 8,4 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
101,00 €
+28.6%
Low: 55,00 €
High: 145,00 €
BPA Prévisionnel
-4,30 €
CA Est.
1,5 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,60 €
-0,25 € – 10,68 €
|
670 M | 4 |
| FY2029 |
-3,70 €
-15,21 € – 0,36 €
|
200 M | 4 |
| FY2028 |
-5,47 €
-8,72 € – -3,31 €
|
19 M | 11 |
Points Clés
Revenue grew 8,37% annually over 5 years — modest growth
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -129,27M
Revenue growth is decelerating — 1Y growth trails 5Y average by 75,72%
Croissance
Revenue Growth (5Y)
8,37%
Revenue (1Y)-67,35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-38,38%
ROIC-26,97%
Net Margin-7973,33%
Op. Margin-8739,34%
Sécurité
Debt / Equity
0,00
Current Ratio13,32
Interest Coverage0,00
Valorisation
P/E Ratio
-17,52
P/B Ratio5,76
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -67,35% | Revenue Growth (3Y) | -15,12% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8,37% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,04M | Net Income (TTM) | -162,34M |
| ROE | -38,38% | ROA | -30,58% |
| Gross Margin | 100,00% | Operating Margin | -8739,34% |
| Net Margin | -7973,33% | Free Cash Flow (TTM) | -129,27M |
| ROIC | -26,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 13,32 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -17,52 | P/B Ratio | 5,76 |
| P/S Ratio | 1397,07 | PEG Ratio | -0,15 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,84B | Enterprise Value | 2,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,04M | 6,24M | 2,83M | 6,42M | 1,48M |
| Net Income | -162,34M | -84,97M | -43,56M | -28,48M | -13,11M |
| EPS (Diluted) | -4,20 | -2,55 | -8,45 | -7,60 | -3,82 |
| Gross Profit | 2,04M | 6,24M | 2,83M | 6,42M | 1,48M |
| Operating Income | -177,93M | -101,86M | -48,17M | -29,71M | -13,09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 530,92M | 374,01M | 179,41M | 83,11M | 189,93M |
| Total Liabilities | 37,52M | 21,53M | 10,54M | 9,45M | 17,26M |
| Shareholders' Equity | 493,40M | 352,48M | 168,87M | 73,66M | 172,67M |
| Total Debt | 1,39M | 1,49M | 585 000,0 | 788 000,0 | 0,0 |
| Cash & Equivalents | 51,09M | 22,79M | 132,33M | 15,37M | 131,65M |
| Current Assets | 409,44M | 280,90M | 177,45M | 82,03M | 180,69M |
| Current Liabilities | 30,73M | 18,45M | 9,63M | 8,23M | 10,86M |